$175M Shareholder Derivative Settlement With Opioid Seller Gains Final Approval
OAKLAND, Calif. — A federal judge in California on April 22 granted final approval to a $175 million shareholder derivative settlement with opioid drug distributor McKesson Corp. stemming from allegations that...To view the full article, register now.
Already a subscriber? Click here to view full article